Answers are grounded in this paper and cite their sources.
This review highlights the importance of selecting specific beta-blockers, such as metoprolol succinate, for the management of cardiovascular diseases based on modern guidelines.
In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the treatment of cardiovascular diseases. Analyzed in detail the selection of b-AB inside the class from the standpoint of pharmacokinetics, selectivity, study in clinical studies. Data about efficiency and safety of application of metoprolol succinate for the treatment of arterial hypertension, coronary heart disease, chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Остроумова et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: